Tag: Covid19 Vaccine

COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax

Hyderabad: The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday. The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin. Joint Drugs Controller Dr S. Eswara Reddy […]

  • Monday, 12 April 2021
Amazon India To Cover Covid-19 Vaccine Cost For 10 Lakh People
Amazon India To Cover Covid-19 Vaccine Cost For 10 Lakh People

New Delhi: As individuals above 45 years of age in the country can now get Covid-19 vaccines, Amazon India on Monday said that it will cover the cost of Covid-19…

  • Monday, 12 April 2021
Aerum-Institute
Serum Institute To Manufacture 200mn Doses Of COVID19 Vaccine

New Delhi: A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100 million doses of safe and effective Covid-19 vaccines for India and low-and middle income countries. This brings the […]

  • Monday, 12 April 2021
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials

Hyderabad: Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in […]

  • Saturday, 10 April 2021
Serum Institute Aims To Have 100m Doses Of AstraZeneca Vaccine Ready By Dec
Serum Institute Aims To Have 100m Doses Of AstraZeneca Vaccine Ready By Dec

New Delhi: Serum Institute of India (SII) is ramping up production of AstraZeneca’s Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that same month, Bloomberg reported. If final-stage trial data show that AstraZeneca’s vaccine candidate is giving effective protection from the virus, SII […]

  • Friday, 09 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
Covaxin's Phase-3 Trials Begin: Bharat Biotech

Hyderabad: Phase-3 trials of Covaxin, India’s first indigenous vaccine for Covid-19 commenced today, vaccine maker Bharat Biotech announced on Monday. The Phase-3 trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). This is India’s first Phase-3 efficacy study for a Covid-19 vaccine, and the […]

  • Friday, 09 April 2021
Odisha: Phase-3 Human Trials Of Covaxin Begins At SUM Hospital
Odisha: Phase-3 Human Trials Of Covaxin Begins At SUM Hospital

Bhubaneswar: The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Friday. This is the only institute in the State chosen by the Indian Council for Medical Research (ICMR) for the human trial of the vaccine. The vaccine was administered to two […]

  • Friday, 09 April 2021
Moderna COVID-19 Vaccine: Govts May Have To Shell Out $25-$37 Per Dose
Moderna COVID-19 Vaccine: Govts May Have To Shell Out $25-$37 Per Dose

Berlin: Governments seeking to purchase Moderna’s potential Covid-19 vaccine may have to shell out $25 and $37 per dose, depending on the size of the order, the company’s CEO Stephane Bancel told German weekly ‘Welt am Sonntag’ (WamS). Bancel said that the price he quoted was a “fair price” and that the company was not […]

  • Friday, 09 April 2021
AstraZeneca Admits Dosing Error In COVID Vax, Faces Tough Questions From Experts
AstraZeneca Admits Dosing Error In COVID Vax, Faces Tough Questions From Experts

New York: Drugmaker AstraZeneca is now facing tough questions from experts after the company admitted a manufacturing error by a contractor. Earlier this week, the drug manufacturer has announced about the promising results from its Covid-19 vaccine trial After disclosing promising results. AstraZeneca on Monday had announced that it recorded positive high-level results from an […]

  • Friday, 09 April 2021
PM Modi To Review COVID-19 Vaccine Work In Hyderabad, Ahmedabad, Pune
PM Modi To Review COVID-19 Vaccine Work In Hyderabad, Ahmedabad, Pune

Ahmedabad/Pune/Hyderabad: Prime Minister Narendra Modi will visit Hyderabad, Ahmedabad and Pune on Saturday to review coronavirus vaccine development work at facilities there, the Prime Minister’s Office (PMO) said. “Tomorrow, PM @narendramodi will embark on a 3 city visit to personally review the vaccine development & manufacturing process. He will visit the Zydus Biotech Park in […]

  • Friday, 09 April 2021
Adar Poonawalla
Serum Institute To Seek Emergency Use Authorisation For Covishield Vaccine In 2 Weeks: Poonawalla

New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation. […]

  • Friday, 09 April 2021
PM Modi Reviews COVID-19 Vaccine Development, Manufacturing In Ahmedabad, Hyderabad, Pune
PM Modi Reviews COVID-19 Vaccine Development, Manufacturing In Ahmedabad, Hyderabad, Pune

Ahmedabad/Hyderabad/Pune: Prime Minister Narendra Modi on Saturday visited Ahmedabad, Hyderabad and Pune to review the development and manufacturing process of coronavirus vaccines at facilities in these cities. He visited the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune. “The scientists expressed joy that the Prime Minister met […]

  • Friday, 09 April 2021
Serum Institute Seeks Rs 100 Cr Damage From Volunteer Seeking Compensation For Complications
Serum Institute Seeks Rs 100 Cr Damage From Volunteer Seeking Compensation For Complications

New Delhi: After a Chennai-based volunteer served a legal notice to the Serum Institute of India (SII) demanding Rs 5 crore compensation for the alleged neurological complications he developed after being administered a test dose of its Covidshield vaccine, the SII has now countered the allegation with a demand of Rs 100 crore as damages […]

  • Friday, 09 April 2021
Moderna Says COVID-19 Vaccine 94% Effective, Seeks Emergency Clearance
Moderna Says COVID-19 Vaccine 94% Effective, Seeks Emergency Clearance

New York: Moderna Inc, which has reported its Covid-19 vaccine is 94 per cent effective, on Monday announced it is filing with US and European regulators for emergency use authorisation. Moderna follows barely a week after Pfizer and its German partner BioNTech filed for US regulatory approval. By the end of 2020, Moderna expects to […]

  • Friday, 09 April 2021
Covishield
Serum Institute Seeks Emergency Use Authorisation For Covishield Vaccine

New Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and […]

  • Thursday, 08 April 2021
scrollToTop